Galvus (Type 2 Diabetes)：市場予測と分析（～2022）...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 8
2 Introduction 9
2.1 Catalyst 9
2.2 Related Reports 10
3 Disease Overview 13
3.1 Etiology and Pathophysiology 13
3.1.1 Etiology 13
3.1.2 Pathophysiology 14
3.1.3 Prognosis 15
3.1.4 Quality of Life 16
3.2 Symptoms 16
4 Disease Management 18
4.1 Treatment Overview 18
4.1.1 Diagnosis and Referrals 18
4.1.2 Treatment Guidelines 19
5 Competitive Assessment 25
5.1 Overview 25
5.2 Strategic Competitor Assessment 26
6 Galvus (vildagliptin) 28
6.1 Overview 28
6.2 Efficacy 29
6.3 Safety 30
6.4 SWOT Analysis 32
6.5 Forecast 32
7 Appendix 34
7.1 Bibliography 34
7.2 Abbreviations 38
7.3 Methodology 39
7.4 Forecasting Methodology 39
7.4.1 Diagnosed Type 2 Patients 39
7.4.2 Percent Drug-Treated Patients 40
7.4.3 Drugs Included in Each Therapeutic Class 40
7.4.4 Launch and Patent Expiry Dates 41
7.4.5 General Pricing Assumptions 41
7.4.6 Individual Drug Assumptions 42
7.4.7 Generic Erosion 42
7.5 Physicians and Specialists Included in this Study 43
7.6 About the Authors 45
7.6.1 Analyst II – CVMD 45
7.6.2 Therapy Director – CVMD and Infectious Disease 45
7.6.3 Global Head of Healthcare 46
7.7 About GlobalData 47
7.8 Disclaimer 47